Article
No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women.
Menopause (New York, N.Y.) - 1 Apr 2014
Passarelli Michael N, Newcomb Polly A, Makar Karen W, Burnett-Hartman Andrea N, Phipps Amanda I, David Sean P, Hsu Li, Harrison Tabitha A, Hutter Carolyn M, Duggan David J, White Emily, Chan Andrew T, Peters Ulrike
Abstract excerpt
OBJECTIVE: Sex steroid hormones play a role in colorectal cancer (CRC) development, but little is known about their influence on tumor progression and metastasis. Because catechol-O-methyltransferase (COMT; 22q11.21) activity is an important component of estrogen-mediated carcinogenesis, we hypothesized that germline variation in COMT may be associated with CRC survival. METHODS: We identified 10 single...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
